P
Panthera Biopartners
Clinical trial site management and patient recruitment services
About Panthera Biopartners
Panthera Biopartners is the United Kingdom's largest independent Site Management Organization (SMO), specializing in conducting Phase II and Phase III clinical trials. Founded in July 2019 by Dr. Ian Smith, who previously founded the world's largest SMO, Synexus, and Professor John Lyon, a former global executive at CRO Covance, the company was established to manage clinical trials and patient recruitment for pharmaceutical companies and Contract Research Organizations (CROs).
The company's business model is centered on its network of dedicated clinical trial facilities across the UK, which provide services including trial planning, patient recruitment, data collection, and patient retention. Panthera serves a blue-chip client base that includes ten of the top twelve global pharmaceutical firms and seven of the top CROs. The firm generates revenue by running trials for these clients, addressing the critical industry challenge of efficient patient recruitment. Panthera operates sites in locations such as Glasgow, York, Sheffield, Preston, Rochdale, and Enfield. These sites are equipped with dedicated sample processing laboratories and are staffed by GCP-trained professionals.
Panthera has demonstrated rapid growth, securing its first institutional investment in 2020 and a further £10 million in 2022 to fund expansion across the UK and Western Europe. In August 2025, private equity firm LDC, part of Lloyds Banking Group, made a significant investment to support further international growth, marking a successful exit for previous investors BGF and Gresham House Ventures. The company has achieved significant milestones, including being the top global recruiter in four international studies in 2024. Its therapeutic expertise covers a broad range of areas traditionally managed in primary care, such as vaccines, cardiovascular disease, diabetes, neurology, respiratory medicine, and has expanded into specialist areas like oncology, NASH, and early dementia.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 143
- Open positions
- None listed
- Dealroom signal
- 85.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform
- Sector
- Biotechnology, Clinical Trials, Hard Tech, Digital Pharma, DT and LS, uk is8 life sciences, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company, latest Apr 2026
- Capital deployed
- —
- Preferred round
- ACQUISITION
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VC✓Equity / VC | Aug 2025 | $0 | — | LDC | ↗ |
| EARLY VC✓Equity / VC | Apr 2022 | $13M | $53M | Business Growth Fund · Gresham House Ventures | ↗ |
Growth signals
Latest recorded traffic for Panthera Biopartners is 170 monthly website visits, down 39.3% over the last three months. Panthera Biopartners's team grew 18.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Panthera Biopartners in the Preston ecosystem
The Panthera Biopartners office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Gresham House Ventures
Business Growth Fund
Series B and later1 investor entered at this stage
LDC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Panthera Biopartners on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Panthera Biopartners’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











